Quick answer
Compounded semaglutide contains the same active molecule as Ozempic and Wegovy. It is manufactured at FDA-registered 503B pharmacies under physician prescription. The main differences are price ($249/mo vs $900–1,200/mo brand-name), availability (no insurance required), and minor formulation variations. Clinical efficacy at equivalent doses is the same.
Medication guide
Compounded Semaglutide
vs Ozempic
Same active ingredient. Very different price. Here's everything you need to know about the difference between compounded semaglutide and brand-name Ozempic — safety, efficacy, regulation, and cost.
The same molecule, different source
Semaglutide is a GLP-1 receptor agonist — a synthetic peptide that mimics the GLP-1 hormone to reduce appetite, slow gastric emptying, and improve insulin sensitivity. Novo Nordisk holds patents on Ozempic (diabetes indication) and Wegovy (weight loss indication) and charges accordingly: $900–$1,200/month without insurance.
Compounded semaglutide is the same peptide, synthesized by FDA-registered compounding pharmacies to a physician's specification. The active ingredient is chemically identical. The price difference — $249/mo at Marrow vs $1,200 brand-name — reflects the absence of patent premiums, marketing budgets, and distribution markups, not any difference in the molecule itself.
The pharmacy tier matters
Not all compounding pharmacies are equal. There are two tiers:
503A pharmacies
State-regulated, patient-specific prescriptions. Lower regulatory bar. Many GLP-1 providers use 503A pharmacies. Quality varies significantly between compounders.
503B outsourcing facilities Marrow uses this
Federally regulated by the FDA. Inspected to pharmaceutical-grade sterility standards. Can produce batches without patient-specific prescriptions. The same tier that supplies hospitals. Significantly higher regulatory bar.
Marrow sources exclusively from FDA-registered 503B facilities. When comparing compounded semaglutide providers, always confirm pharmacy tier — it's the most meaningful quality signal available.
What's actually different
| Factor | Compounded (Marrow) | Ozempic / Wegovy |
|---|---|---|
| Active ingredient | Semaglutide (identical) | Semaglutide (identical) |
| Price | $249/mo | $900–$1,200/mo (without insurance) |
| Insurance | Not required | Often not covered; varies |
| Pharmacy | FDA-registered 503B | Novo Nordisk manufacturing |
| Formulation | Compounded — may vary | Pen injector, set doses |
| FDA approval | Not FDA-approved drug product | FDA-approved |
| Availability | No shortage | Periodic shortage history |
| Tirzepatide available | Yes — from $339/mo | No (different brand/company) |
Should you consider tirzepatide instead?
If weight loss is the primary goal, tirzepatide is worth considering. The SURMOUNT trials showed 21% average body weight reduction over 72 weeks — significantly better than semaglutide's 15%. Tirzepatide works on both GLP-1 and GIP receptors (dual mechanism), which appears to drive superior fat loss.
Marrow offers compounded tirzepatide starting at $339/mo — still significantly less than brand-name Mounjaro ($1,400/mo). A physician will help determine which is the better fit during your intake review.
Common questions
Is compounded semaglutide the same as Ozempic?
Compounded semaglutide contains the same active ingredient (semaglutide) as Ozempic and Wegovy. It is manufactured by FDA-registered compounding pharmacies under physician prescription. The active molecule is identical — the differences are in formulation, inactive ingredients, and price.
Is compounded semaglutide safe?
Compounded semaglutide from FDA-registered 503B pharmacies has a strong safety track record. 503B outsourcing facilities are federally regulated, undergo FDA inspections, and maintain pharmaceutical-grade sterility standards. The risk profile at equivalent doses is the same as brand-name Ozempic.
Why is compounded semaglutide so much cheaper than Ozempic?
Ozempic's price ($900–$1,200/mo without insurance) reflects Novo Nordisk's patent monopoly, marketing costs, and distribution margins. Compounding pharmacies synthesize the same molecule without those markups. Marrow passes these savings directly to patients — starting at $249/mo.
Will compounded semaglutide still be available in 2026?
As of 2026, compounded semaglutide remains available through telehealth providers and physician prescription. The FDA has not banned compounded semaglutide, though the regulatory environment may change as the brand-name shortage resolves. Marrow monitors this closely and will communicate any changes proactively.
What about tirzepatide vs semaglutide — which is better?
Clinical trials show tirzepatide (Mounjaro/Zepbound) produces 21% average body weight reduction vs 15% for semaglutide. Tirzepatide is a dual GIP/GLP-1 receptor agonist vs semaglutide's single GLP-1 mechanism — the dual action appears to drive superior results. Marrow offers both, and a physician can help determine which fits your goals.
How do I get compounded semaglutide online?
Through a telehealth provider like Marrow: complete a 5-minute intake, a licensed physician reviews within 24 hours, and compounded semaglutide ships from an FDA-registered 503B pharmacy to your door in 3–5 days.
Start for $249/mo
Compounded semaglutide from a 503B pharmacy. Physician review in 24hr. Ships in 3–5 days.
Start your intake →